Five things for pharma marketers to know: Tuesday, July 16, 2019
Oklahoma prosecutors compare J&J to drug ‘kingpin’; Biden unveils healthcare plan; Gilead increases stake in Galapagos.
Roundup
Five things for pharma marketers to know: Monday, July 15, 2019
Feds to pursue criminal investigation into J&J; 23andMe wants access to medical records alongside DNA; Another Alzheimer’s trial fails.
Five things for pharma marketers to know: Friday, July 12, 2019
CVS to expand health-focused stores; Reckitt Benckiser to pay $1.4 billion to end opioid probes; House committee discusses marijuana legalization.
Five things for pharma marketers to know: Thursday, July 11, 2019
Federal Reserve chair says opioid crisis has had ‘quite substantial’ economic impact; GSK hires Genentech veteran to oversee AI; Amazon partners with Britain’s NHS.
Five things for pharma marketers to know: Wednesday, July 10, 2019
Oklahoma case against J&J to continue; Judge strikes down drug price advertising disclosure rule; Novartis steps in with generic EpiPen as shortage continues.
Five things for pharma marketers to know about the Agency 100: Tuesday, July 9, 2019
It’s finally here. MM&M delivers the most comprehensive guide to the medical marketing universe.
Five things for pharma marketers to know: Monday, July 8, 2019
Agency 100 preview; Canopy Growth fires CEO; Five states to suspend litigation against Insys.
Five things for pharma marketers to know: Wednesday, July 3, 2019
Warren says Gottlieb should quit Pfizer board; Facebook cracks down on outrageous drug claims; Number of drug price increases up 17% over last year.
Five things for pharma marketers to know: Tuesday, July 2, 2019
A healthcare pledge that could come back to haunt Democrats; American Pain Society closes; Bayer backs biotech startup Century Therapeutics.
Five things for pharma marketers to know: Monday, July 1, 2019
Harris restates private coverage debate answer; Gottlieb joins Pfizer board; Best strategies for dealing with trolls.
Five things for pharma marketers to know: Friday, June 28, 2019
Panel urges millions of hepatitis A vaccinations; Another Apple healthcare move; Google accused of inappropriately accessing medical records.
Five things for pharma marketers to know: Thursday, June 27, 2019
Omada Health raises $73 million; Key judicial decision on Insys coming next month; Apple Watch, Fitbit integrate Livongo services.
Five things for pharma marketers to know: Wednesday, June 26, 2019
AbbVie to buy Allergan; Judge blocks generics of Novartis’ Gilenya; Illinois becomes 11th state to legalize recreational marijuana.
Five things for pharma marketers to know: Tuesday, June 25, 2019
Trump signs transparency executive order; BMS-Celgene deal to close later than expected; CDC turns to Mutombo to block ebola.
Five things for pharma marketers to know: Monday, June 24, 2019
Gottlieb: Juul in a ‘tough spot’ for FDA approval; Trump expected to issue healthcare transparency executive order; Second female libido drug awaits approval.
Want to read more?
Please login or register first to view this content.
